In fact, it was previously described that treatment with human MSCs could enhance the levels of the neurotrophic factors IGF-1 and VEGF in cerebellar and serum samples of SCA3 animals [37]. The gene discussed is VEGFA; the disease is Spinocerebellar ataxia type 3.